Loss of DAB2IP Contributes to Cell Proliferation and Cisplatin Resistance in Gastric Cancer

OBJECTIVE: Resistance to chemotherapeutic drugs, such as cisplatin, has been one of the major problems adversely affecting the clinical prognosis of patients with gastric cancer (GC). Disabled Homolog 2-Interacting Protein (DAB2IP) status is one of the major factors involved in sensitivity to chemot...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Guannan, Wang, Xu, Han, Meng, Wang, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884952/
https://www.ncbi.nlm.nih.gov/pubmed/33603402
http://dx.doi.org/10.2147/OTT.S289722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884952/
https://www.ncbi.nlm.nih.gov/pubmed/33603402
http://dx.doi.org/10.2147/OTT.S289722

Ejemplares similares